Sensus Healthcare, Inc. Stock price

Equities

SRTS

US81728J1097

Advanced Medical Equipment & Technology

Market Closed - Nasdaq 04:30:00 2024-03-28 pm EDT 5-day change 1st Jan Change
3.8 USD -3.06% Intraday chart for Sensus Healthcare, Inc. -0.26% +61.02%
Sales 2024 * 26.63M Sales 2025 * 32.48M Capitalization 62.3M
Net income 2024 * - Net income 2025 * 3M EV / Sales 2024 * 2.34 x
Net cash position 2024 * - Net cash position 2025 * - EV / Sales 2025 * 1.92 x
P/E ratio 2024 *
127 x
P/E ratio 2025 *
21.1 x
Employees 35
Yield 2024 *
-
Yield 2025 *
-
Free-Float 76.13%
More Fundamentals * Assessed data
Dynamic Chart
Transcript : Sensus Healthcare, Inc., Q4 2023 Earnings Call, Feb 08, 2024
Sensus Healthcare, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 CI
Earnings Flash (SRTS) SENSUS HEALTHCARE Posts Q4 Revenue $12.6M, vs. Street Est of $12.1M MT
Sensus Healthcare Announces Directors Changes CI
Sensus Healthcare, Inc. Provides Revenue Guidance for the Fourth Quarter and Full Year Ended December 31, 2023 CI
Sensus Healthcare, Inc. Appoints Michael Sardano as A Director, Effective February 1, 2024 CI
Tranche Update on Sensus Healthcare, Inc.'s Equity Buyback Plan announced on August 8, 2023. CI
Transcript : Sensus Healthcare, Inc., Q3 2023 Earnings Call, Nov 09, 2023
Earnings Flash (SRTS) SENSUS HEALTHCARE Posts Q3 Revenue $3.9M MT
Sensus Healthcare, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Sensus Healthcare to Showcase its Full Line of Cutting-Edge Superficial Radiotherapy Devices for the Treatment of Non-melanoma Skin Cancer at ASTRO 2023 in San Diego CI
Sensus Healthcare, Inc.(NasdaqCM:SRTS) dropped from S&P Global BMI Index CI
Sensus Healthcare, Inc. Enters into A Credit Agreement with Comerica Bank CI
Tranche Update on Sensus Healthcare, Inc.'s Equity Buyback Plan announced on March 9, 2022. CI
Sensus Healthcare Launches $3 Million Stock Buyback Program; Shares Surge 15% Midday MT
More news
1 day-3.06%
1 week-0.26%
Current month-7.32%
1 month-15.37%
3 months+58.33%
6 months+43.40%
Current year+61.02%
More quotes
1 week
3.65
Extreme 3.65
4.02
1 month
2.91
Extreme 2.91
4.33
Current year
2.36
Extreme 2.3648
5.38
1 year
1.79
Extreme 1.79
5.38
3 years
1.79
Extreme 1.79
15.25
5 years
1.76
Extreme 1.7603
15.25
10 years
1.76
Extreme 1.7603
15.25
More quotes
Managers TitleAgeSince
Founder 71 10-05-06
Chief Executive Officer 71 10-05-06
Director of Finance/CFO 52 14-12-31
Members of the board TitleAgeSince
Chief Executive Officer 71 10-05-06
Director/Board Member 71 16-07-20
Director/Board Member 77 12-01-31
More insiders
Date Price Change Volume
24-03-28 3.8 -3.06% 53,111
24-03-27 3.92 -1.75% 46,076
24-03-26 3.99 +6.12% 174,573
24-03-25 3.76 -0.27% 104,085
24-03-22 3.77 -1.05% 144,645

Delayed Quote Nasdaq, March 28, 2024 at 04:30 pm EDT

More quotes
Sensus Healthcare, Inc. is a medical device company. The Company is focused on providing non-invasive treatments for both oncological and non-oncological skin conditions. The Company uses a low-energy X-ray technology known as superficial radiation therapy (SRT). The Company incorporated SRT into its portfolio of treatment devices: the SRT-100, SRT-100+ and SRT-100 Vision. SRT-100, is a photon x-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers and other skin conditions such as keloids. The SRT-100 Vision provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. Its SRT-100+ offer remote diagnostics solutions, including operation tracking.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
3.8 USD
Average target price
7 USD
Spread / Average Target
+84.21%
Consensus
  1. Stock
  2. Equities
  3. Stock Sensus Healthcare, Inc. - Nasdaq